BRIGHT MINDS BIOSCIENCES
Bright Minds is focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and pain. Bright Minds has a portfolio of next generation serotonin agonists designed to precisely target abnormalities in neurocircuitry that lead to dysfunctional behaviors. The Company is developing targeted therapies with the potential to improve the treatment of mental health and neurological disorders through the use of serotonergic compounds leveraging its world class scientific a... nd drug development expertise to bring forward the next generation of safe and efficacious drugs. Bright Minds drugs extenuate the therapeutic aspects of psychedelic and other serotonergic compounds while minimizing the side effects thereby creating superior drugs to first generation compounds, such as psilocybin.
BRIGHT MINDS BIOSCIENCES
Industry:
Biotechnology Health Care Medical
Founded:
2017-11-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.brightmindsbio.com
Total Employee:
1+
Status:
Active
Total Funding:
4.68 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Current Employees Featured
Ryan Cheung Chief Financial Officer @ Bright Minds Biosciences
Chief Financial Officer
Alan Kozikowski Co-Founder, Chief Scientific Officer & Board Member @ Bright Minds Biosciences
Co-Founder, Chief Scientific Officer & Board Member
Revati Shreeniwas Chief Medical Officer @ Bright Minds Biosciences
Chief Medical Officer
Ian Macdonald Co-Founder, Chief Executive Officer & Board Member @ Bright Minds Biosciences
Co-Founder, Chief Executive Officer & Board Member
Gideon Shapiro Co-Founder & Vice President of Discovery @ Bright Minds Biosciences
Co-Founder & Vice President of Discovery
Founder
Stock Details
Official Site Inspections
http://www.brightmindsbio.com Semrush global rank: 2.62 M Semrush visits lastest month: 6.6 K
- Host name: gator4157.hostgator.com
- IP address: 108.167.140.133
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
More informations about "Bright Minds Biosciences"
Bright Minds Biosciences Announces Changes to its Executive …
Vancouver, BC – June 27, 2022 – Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing …See details»
Bright Minds Biosciences - Crunchbase Company …
Contact Email info@brightmindsbio.com Bright Minds is focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and …See details»
Bright Minds Biosciences - businessabc
Feb 25, 2025 https://brightmindsbio.com Dive deeper into fresh insights across Business , Industry Leaders and Influencers , Organizations , Education , and Investors for a …See details»
Bright Mind - Overview, News & Similar companies - ZoomInfo
Jun 22, 2023 Bright Mind contact info: Phone number: (647) 407-2515 Website: www.brightmindsbio.com What does Bright Mind do? Bright Minds is focused on developing …See details»
Bright Minds Biosciences Appoints Pharmaceutical Leader, …
Jan 7, 2025 — Dr. Collins brings extensive drug development and clinical expertise in epilepsy — New York and Vancouver, BC – January 07, 2025 – Bright Minds Biosciences, Inc. (“Bright …See details»
Bright Minds Biosciences Inc. | The Canadian Securities Exchange …
Brightmindsbio.com. Bright Minds is a pre-clinical biosciences company with a portfolio of compounds designed to precisely target abnormalities in neurocircuitry that lead to …See details»
Bright Minds Biosciences - Craft
Oct 29, 2024 Bright Minds Biosciences is a company that engages in the development of serotonergic therapeutics solutions. It offers treatments for epilepsy, pain, and neuropsychiatry.See details»
Bright Minds 2025 Company Profile: Stock …
Information on stock, financials, earnings, subsidiaries, investors, and executives for Bright Minds. Use the PitchBook Platform to explore the full profile.See details»
Bright Minds Biosciences - VentureRadar
"Bright Minds is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. Bright Minds has a portfolio of next-generation serotonin …See details»
Bright Minds Biosciences - News, Mergers and Acquisitions, …
1: 11-27-2024: Bright Minds Biosciences participates in a conference call with Truist | Nasdaq: Events and Conferences: 2: 11-22-2024: Bright Minds Biosciences to Present Data at the …See details»
Bright Minds Biosciences to Participate at Three Healthcare
Feb 24, 2025 NEW YORK and VANCOUVER, British Columbia, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) …See details»
Bright Minds Biosciences to Participate at Three Healthcare …
Feb 24, 2025 About Bright Minds Biosciences. Bright Minds Biosciences is a biotechnology company developing innovative treatments for patients with neurological and psychiatric …See details»
BMB-201 - Drug Targets, Indications, Patents - Synapse
Jan 23, 2025 Originator Organization. Bright Minds Biosciences, Inc. Active Organization. Bright Minds Biosciences, Inc. Inactive Organization-Drug Highest Phase Preclinical. First Approval …See details»
Our Science - Next-Generation Therapeutics - Bright Minds
Bright Minds Biosciences has a strong translational science foundation to support our drug development. We have a rich and growing library of proprietary compounds targeting the 5-HT …See details»
Bright Minds Biosciences announces participation in upcoming …
Oct 3, 2024 Bright Minds Biosciences will present scientific posters about various programs in development, including BMB-101, BMB-201 and BMB-202; Bright Minds Biosciences will …See details»
BMB-101 - Drug Targets, Indications, Patents - Synapse - Patsnap
Jan 23, 2025 Contact Information Alex VasilkevichChief Operating OfficerBright Minds Biosciences Inc. T: 414-731-6422E: alex@brightmindsbio.com Website: …See details»
Bright Minds Biosciences to Host Investor & Analyst KOL Event on ...
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (NASDAQ / CSE: DRUG) announces the Key Opinion Leader (KOL) event with leading experts in epilepsy …See details»
Bright Minds Biosciences to Present Data at the American Epilepsy ...
Nov 21, 2024 Poster presentations on BMB-101 will focus on 5-HT 2C functional selectivity and Phase 1 clinical data – ; NEW YORK, November 21, 2024 – Bright Minds Biosciences Inc. …See details»
Establishing Canada’s first large-scale bioinnovation centre
2 days ago The Neptune BioInnovation Centre (NBC), a 51,000 sq ft facility on a 12.3 acre lot in Dartmouth, will offer leasable wet and dry lab space, warehouse and office spaces, and …See details»
Bright Minds Biosciences to Participate at Three Healthcare …
Feb 24, 2025 NEW YORK and VANCOUVER, British Columbia, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) …See details»